FMC and Corteva announced on Tuesday (16) a strategic agreement for the co-exclusive supply and licensing of the rimisoxafen herbicide technology for the soybean and corn markets in North and South America. Under the terms of the agreement, valid for the next decade, FMC will retain intellectual property rights to rimisoxafen and will be responsible for supplying the active ingredient to Corteva. As part of the partnership, Corteva will make an advance payment of US$200 million for the pre-purchase of products to be supplied by FMC. According to a statement from the companies, both will develop and market their own exclusive premix formulations for use in soybean and corn crops on both continents. Rimisoxafen was developed to control resistant weeds, including species of the genus Amaranthus, one of the main phytosanitary challenges faced by soybean and corn producers in several agricultural regions. According to the companies, the Herbicide Resistance Action Committee (HRAC) classified rimisoxafen as the industry's first herbicide with a dual mode of action, a feature that expands its control potential and contributes to weed resistance management.
This text was translated by machine from Brazilian Portuguese.